Biote (BTMD) vs Philip Morris International (PM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Philip Morris International (PM) has outperformed Biote (BTMD) over the past year, gaining 24.7% versus a loss of 60.9%. Over five years, PM leads with a +95.9% price change compared with -88.6% for BTMD. Philip Morris International is the larger company by market cap ($300.33 billion vs $37.6 million), about 7981.5 times the size.
On valuation, Biote trades at a lower forward P/E (2.5x vs 21.0x for Philip Morris International). Philip Morris International pays a dividend yielding 3.05%, while Biote does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BTMD | PM |
|---|---|---|
| Share price | $1.11 | $192.69 |
| Market cap | $37.63M | $300.33B |
| 1-day change | -2.63% | +1.20% |
| YTD return | -57.31% | +20.13% |
| 1-year return | -60.92% | +24.68% |
| 5-year return | -88.64% | +95.88% |
| P/E ratio (TTM) | 7.93 | 27.69 |
| Forward P/E | 2.47 | 20.98 |
| EPS (TTM) | $0.14 | $6.96 |
| Dividend yield | 0.00% | 3.05% |
| Annual dividend | $0.00 | $5.88 |
| Revenue (latest FY) | — | $40.65B |
| Revenue growth (YoY) | — | +7.31% |
| Net income (latest FY) | — | $11.35B |
| Gross margin | — | 67.12% |
| Operating margin | — | 36.64% |
| Net margin | — | 27.92% |
| 52-week high | $3.26 | $207.76 |
| 52-week low | $1.09 | $142.11 |
| Distance from 52-week high | -65.95% | -7.25% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +8.01% |
| Average volume | 230.83K | 4.66M |
| Shares outstanding | 28.68M | 1.56B |
| Employees | — | 84,900 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Philip Morris International is about 7981.5 times larger than Biote by market value ($300.33B vs $37.63M).
- PM has outperformed BTMD by 85.6 percentage points over the past year.
- Philip Morris International trades at a higher earnings multiple (27.7x vs 7.9x trailing P/E).
- Philip Morris International offers a meaningfully higher dividend yield (3.05% vs 0.00%).
About Philip Morris International
PM stock →Philip Morris International Inc. operates as a tobacco company.
Health Care · Medicinal Chemicals and Botanical Products · 84,900 employees
BTMD vs PM FAQ
Which is bigger, Biote or Philip Morris International?
Philip Morris International (PM) is larger, with a market capitalization of $300.33B compared with $37.63M for Biote (BTMD).
Which stock has performed better over the past year, BTMD or PM?
PM returned +24.68% over the past 12 months, compared with -60.92% for BTMD (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, BTMD or PM?
BTMD has the lower trailing P/E at 7.9, versus 27.7 for PM. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Biote or Philip Morris International?
Philip Morris International pays a dividend yielding 3.05%, while Biote does not currently pay a regular dividend.
Are Biote and Philip Morris International in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.